TC-I 15

CAS# 916734-43-5

TC-I 15

Catalog No. BCC6216----Order now to get a substantial discount!

Product Name & Size Price Stock
TC-I 15: 5mg $138 In Stock
TC-I 15: 10mg Please Inquire In Stock
TC-I 15: 20mg Please Inquire Please Inquire
TC-I 15: 50mg Please Inquire Please Inquire
TC-I 15: 100mg Please Inquire Please Inquire
TC-I 15: 200mg Please Inquire Please Inquire
TC-I 15: 500mg Please Inquire Please Inquire
TC-I 15: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of TC-I 15

Number of papers citing our products

Chemical structure

TC-I 15

3D structure

Chemical Properties of TC-I 15

Cas No. 916734-43-5 SDF Download SDF
PubChem ID 90488948 Appearance Powder
Formula C23H28N4O6S2 M.Wt 520.62
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble to 100 mM in DMSO and to 25 mM in 1.1eq. NaOH
Chemical Name (2S)-2-[[(4R)-3-(benzenesulfonyl)-5,5-dimethyl-1,3-thiazolidine-4-carbonyl]amino]-3-(benzylcarbamoylamino)propanoic acid
SMILES CC1(C(N(CS1)S(=O)(=O)C2=CC=CC=C2)C(=O)NC(CNC(=O)NCC3=CC=CC=C3)C(=O)O)C
Standard InChIKey XKLHCUGVLCGKKX-RBUKOAKNSA-N
Standard InChI InChI=1S/C23H28N4O6S2/c1-23(2)19(27(15-34-23)35(32,33)17-11-7-4-8-12-17)20(28)26-18(21(29)30)14-25-22(31)24-13-16-9-5-3-6-10-16/h3-12,18-19H,13-15H2,1-2H3,(H,26,28)(H,29,30)(H2,24,25,31)/t18-,19+/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of TC-I 15

DescriptionPotent α2β1 integrin inhibitor (IC50 values for the inhibition of human platelet adhesion to type I collagen are 12 and 715 nM for platelets under static conditions and under flow, respectively). Displays selectivity for α2β1 over αvβ3, α5β1, α6β1 and αIIbβ3 at concentrations exceeding 1000 nM. Reduces collagen IV production in mesangial cells. Active in vivo; prevents ferric chloride-induced clot formation in mice.

TC-I 15 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

TC-I 15 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of TC-I 15

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.9208 mL 9.6039 mL 19.2079 mL 38.4157 mL 48.0197 mL
5 mM 0.3842 mL 1.9208 mL 3.8416 mL 7.6831 mL 9.6039 mL
10 mM 0.1921 mL 0.9604 mL 1.9208 mL 3.8416 mL 4.802 mL
50 mM 0.0384 mL 0.1921 mL 0.3842 mL 0.7683 mL 0.9604 mL
100 mM 0.0192 mL 0.096 mL 0.1921 mL 0.3842 mL 0.4802 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on TC-I 15

Inhibition of integrin alpha2beta1 ameliorates glomerular injury.[Pubmed:22440900]

J Am Soc Nephrol. 2012 Jun;23(6):1027-38.

Mesangial cells and podocytes express integrins alpha1beta1 and alpha2beta1, which are the two major collagen receptors that regulate multiple cellular functions, including extracellular matrix homeostasis. Integrin alpha1beta1 protects from glomerular injury by negatively regulating collagen production, but the role of integrin alpha2beta1 in renal injury is unclear. Here, we subjected wild-type and integrin alpha2-null mice to injury with adriamycin or partial renal ablation. In both of these models, integrin alpha2-null mice developed significantly less proteinuria and glomerulosclerosis. In addition, selective pharmacological inhibition of integrin alpha2beta1 significantly reduced adriamycin-induced proteinuria, glomerular injury, and collagen deposition in wild-type mice. This inhibitor significantly reduced collagen synthesis in wild-type, but not integrin alpha2-null, mesangial cells in vitro, demonstrating that its effects are integrin alpha2beta1-dependent. Taken together, these results indicate that integrin alpha2beta1 contributes to glomerular injury by positively regulating collagen synthesis and suggest that its inhibition may be a promising strategy to reduce glomerular injury and proteinuria.

Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism.[Pubmed:19141632]

Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):719-24.

There is a grave need for safer antiplatelet therapeutics to prevent heart attack and stroke. Agents targeting the interaction of platelets with the diseased vessel wall could impact vascular disease with minimal effects on normal hemostasis. We targeted integrin alpha(2)beta(1), a collagen receptor, because its overexpression is associated with pathological clot formation whereas its absence does not cause severe bleeding. Structure-activity studies led to highly potent and selective small-molecule inhibitors. Responses of integrin alpha(2)beta(1) mutants to these compounds are consistent with a computational model of their mode of inhibition and shed light on the activation mechanism of I-domain-containing integrins. A potent compound was proven efficacious in an animal model of arterial thrombosis, which demonstrates in vivo efficacy for inhibition of this platelet receptor. These results suggest that targeting integrin alpha(2)beta(1) could be a potentially safe, effective approach to long-term therapy for cardiovascular disease.

Keywords:

TC-I 15,916734-43-5,Natural Products,Integrin, buy TC-I 15 , TC-I 15 supplier , purchase TC-I 15 , TC-I 15 cost , TC-I 15 manufacturer , order TC-I 15 , high purity TC-I 15

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: